| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/12/2013 | CN101432307B Cytotoxicity mediation of cells evidencing surface expression of CD44 |
| 06/12/2013 | CN101421416B Method for designing polypeptides for the nanofabrication of thin films, coatings and microcapsules by electrostatic layer-by-layer self assembly |
| 06/12/2013 | CN101410410B Process for preparing human G-CSF |
| 06/12/2013 | CN101307106B Endothelial cell proliferation inhibitor and method of use |
| 06/12/2013 | CN101198623B Methods and compositions for modulating and detecting WISP activity |
| 06/12/2013 | CN101193911B Cysteine-depleted hydrophobin fusion proteins, their production and use thereof |
| 06/12/2013 | CN101166976B ELISA assays using prion-specific peptide reagents |
| 06/12/2013 | CN101006099B Thyrotropin receptor preparations, binding regions thereof, antibody and hormone interactions therewith, and uses thereof |
| 06/11/2013 | US8463710 System and method for processing tokenless biometric electronic transmissions using an electronic rule module clearinghouse |
| 06/11/2013 | US8461436 Plants and seeds of corn variety CV741729 |
| 06/11/2013 | US8461422 DIG-5 insecticidal Cry toxins |
| 06/11/2013 | US8461421 Toxin genes and methods for their use |
| 06/11/2013 | US8461323 Characterization of granulocytic ehrlichia and methods of use |
| 06/11/2013 | US8461321 Nucleic acids encoding a deletion variant of uPAR |
| 06/11/2013 | US8461320 Metabolism mutant; nucleic acid cassette |
| 06/11/2013 | US8461311 TRAIL trimers, methods and uses therefor |
| 06/11/2013 | US8461309 Inhibitor protein of the wnt signal pathway |
| 06/11/2013 | US8461306 Therapeutic use of anti-CS1 antibodies |
| 06/11/2013 | US8461302 Using immobilized metal affinity chromatography (IMAC) to recover blood coagulation factor from cell lysate |
| 06/11/2013 | US8461301 Synthetic dragline spider silk-like proteins |
| 06/11/2013 | US8461119 Peptides, peptidomimetics; promoting programmed cell death; neural regeneration |
| 06/11/2013 | US8461115 Methods for local treatment with factor VII |
| 06/11/2013 | US8461110 Heterodimeric peptide compounds displaying NGF activity and their use to treat neurodegenerative disorders |
| 06/11/2013 | US8461109 Method of enhancing the acceptance and/or healing of a skin graft |
| 06/11/2013 | US8461105 Polymer-based sustained release device |
| 06/11/2013 | US8461103 Modulation of CD4+ T cell responses by a tick saliva protein, Salp15 and polypeptides derived therefrom |
| 06/11/2013 | US8460927 B7-H1 antibodies and method of use |
| 06/11/2013 | US8460894 Calcium-sensing receptor 2 (CaR2) and methods for using |
| 06/11/2013 | US8460885 Binding of pathological forms of prion proteins |
| 06/11/2013 | US8460882 Cancer biomarkers |
| 06/11/2013 | US8460881 Nucleic acids and corresponding proteins entitled 254P1D6B useful in treatment and detection of cancer |
| 06/11/2013 | US8460880 Compositions, splice variants and methods relating to ovarian specific genes and proteins |
| 06/11/2013 | US8460873 Pancreatic cancer genes |
| 06/11/2013 | US8460864 Methods for identifying compounds that modulate untranslated region-dependent gene expression and methods of using same |
| 06/11/2013 | US8460683 Protein or glycoprotein from Haliotis midae and its use as an immunotherapy agent |
| 06/11/2013 | US8460678 Use of triplex structure DNA in transferring nucleotide sequences |
| 06/11/2013 | US8460675 Viral chemokine-antigen fusion proteins |
| 06/11/2013 | US8460674 HSV-1 epitopes and methods for using same |
| 06/11/2013 | US8460661 Methods of using antibodies that bind the glutamate ligand binding region of Notch1 |
| 06/11/2013 | US8460647 Pre-ligand assembly domain of the IL-17 receptor |
| 06/11/2013 | CA2643508C Process for obtaining high efficiency human albumin for use in detoxification therapy |
| 06/11/2013 | CA2560581C Pluripotent stem cell growing method |
| 06/11/2013 | CA2533512C Antagonists and agonists of ldcam and methods of use |
| 06/11/2013 | CA2513388C Employment of rotavirus proteins, derived proteins and peptides for the modulation of tissue permeability |
| 06/11/2013 | CA2510378C Preparation of antifreeze protein |
| 06/11/2013 | CA2498004C Compositions and methods for the diagnosis and treatment of tumor |
| 06/11/2013 | CA2482607C Antibodies, recombinant antibodies, recombinant antibody fragments and fusions mediated plant disease resistance against fungi |
| 06/11/2013 | CA2481349C Peptides for detection of antibody to a. phagocytophilum |
| 06/11/2013 | CA2469336C Guanidinium transport reagents and conjugates |
| 06/11/2013 | CA2467927C Antimicrobial polypeptides from pseudoplectania nigrella |
| 06/11/2013 | CA2451002C Cytochrome p-450 gene cluster from rhodococcus ruber and uses thereof in ether fuel cleavage |
| 06/11/2013 | CA2448835C Use of follistatin to increase muscle mass |
| 06/11/2013 | CA2437453C Conformationally abnormal forms of tau proteins and specific antibodies thereto |
| 06/11/2013 | CA2437064C Storage-stable, liquid fibrinogen formulation |
| 06/11/2013 | CA2426012C Antibacterial agents comprising conjugates of glycopeptides and peptidic membrane-associating elements |
| 06/11/2013 | CA2407959C Human wingless-like gene |
| 06/11/2013 | CA2407603C Porphyromonas gingivalis recombinant proteins and truncations |
| 06/11/2013 | CA2406839C G-protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same |
| 06/11/2013 | CA2405750C Protein kinase stress-related proteins and methods of use in plants |
| 06/11/2013 | CA2405473C Dna molecules encoding ligand gated ion channels from dermacentor variabilis |
| 06/11/2013 | CA2388461C Highly conserved genes and their use to generate probes and primers for the detection of microorganisms |
| 06/11/2013 | CA2377381C Neovascular-targeted immunoconjugates |
| 06/11/2013 | CA2267664C Human telomerase reverse transcriptase |
| 06/11/2013 | CA2229307C Circular dna molecule with conditional origin of replication, method for preparing same and use thereof in gene therapy |
| 06/06/2013 | WO2013082563A1 Protein inhibitors to complement and vegf pathways and methods of use thereof |
| 06/06/2013 | WO2013082200A1 Novel enhanced selectin antagonists |
| 06/06/2013 | WO2013082114A1 Use of p3 of bacteriophage as amyloid binding agents |
| 06/06/2013 | WO2013081612A1 Vectors and host cells comprising a modified sv40 promoter for protein expression |
| 06/06/2013 | WO2013081571A2 Isolated lyssavirus nucleic acid and protein sequences |
| 06/06/2013 | WO2013081554A1 Gm1 ganglioside to annexin v microparticle polypeptide ratio for biological monitoring |
| 06/06/2013 | WO2013081540A1 Affinity chromatography matrix |
| 06/06/2013 | WO2013081233A1 Cell killing fusion peptide exhibiting tumor cell-specific necrosis induction and tumor regression |
| 06/06/2013 | WO2013081091A1 Drug for producing radiolabeled polypeptide reducing non-specific renal accumulation |
| 06/06/2013 | WO2013080973A1 Qsd1 gene governing seed dormancy of plants, and use thereof |
| 06/06/2013 | WO2013080184A1 Chimeric protein comprising proinsulin fused to thioredoxin |
| 06/06/2013 | WO2013080153A1 Inotropic compounds |
| 06/06/2013 | WO2013080147A2 Anticancer fusion protein |
| 06/06/2013 | WO2013080134A2 Anti-fh aptamers, method for producing same, and uses thereof |
| 06/06/2013 | WO2013080133A1 Fluorinated hydrophobin and uses thereof |
| 06/06/2013 | WO2013079721A1 Marker and method for diagnosing diarrhea syndrome |
| 06/06/2013 | WO2013079473A1 Influenza virus vaccines and uses thereof |
| 06/06/2013 | WO2013079456A1 Clonable tag for correlative light and electron microscopy labeling |
| 06/06/2013 | WO2013079208A1 Method for producing a protein hydrolysate |
| 06/06/2013 | WO2013079207A1 Novel targets of acinetobacter baumannii |
| 06/06/2013 | WO2013079015A1 Polypeptides having beta-xylosidase activity and polynucleotides encoding same |
| 06/06/2013 | WO2013078889A1 The method for preparing exenatide by natural coupling |
| 06/06/2013 | WO2013052859A3 Adenoviral vector-based respiratory syncytial virus (rsv) vaccine |
| 06/06/2013 | WO2013052832A3 Simian (gorilla) adenovirus or adenoviral vectors and methods of use |
| 06/06/2013 | WO2013032999A8 Polydnavirus vectors |
| 06/06/2013 | WO2013024043A3 In vivo screening models for treatment of qc-related disorders |
| 06/06/2013 | WO2013016428A3 Recombinant apoa-1m from engineered bacteria |
| 06/06/2013 | WO2012170304A3 Plants with elevated levels of glucan |
| 06/06/2013 | WO2012061530A8 Oplophorus-derived luciferases, novel coelenterazine substrates, and methods of use |
| 06/06/2013 | US20130144048 Therapeutic compositions |
| 06/06/2013 | US20130144043 Polysialic acid derivatives |
| 06/06/2013 | US20130144042 B7-related nucleic acids and polypeptides useful for immunomodulation |
| 06/06/2013 | US20130144038 CRYSTAL STRUCTURE OF A MarR FAMILY POLYPEPTIDE |
| 06/06/2013 | US20130143949 G-CSF Transferrin Fusion Proteins |
| 06/06/2013 | US20130143944 Chemo- and radiation-sensitization of cancer by antisense trpm-2 oligodeoxynucleotides |
| 06/06/2013 | US20130143824 Compositions and methods for enhancing apoptosis |